Domov › Burkitov lymfóm › Illinois › Chicago
Klinické štúdie Burkitov lymfóm v meste Chicago, IL
14 štúdií pre Burkitov lymfóm hľadá účastníkov v zariadeniach v meste Chicago a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
Prebieha náborFáza 2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Prebieha náborFáza 3
- Northwestern University, Chicago
- Rush MD Anderson Cancer Center, Chicago
- University of Illinois, Chicago
- a 1 ďalších
Blinatumomab Consolidation in Real World
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Northwestern University, Chicago
- The University of Chicago, Chicago
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
Prebieha náborFáza 2
- Northwestern University, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Prebieha náborFáza 2
- Lurie Children's Hospital-Chicago, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
Prebieha náborFáza 2
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Prebieha náborFáza 3
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Prebieha náborFáza 2
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Prebieha náborFáza 1/2
- Research Site, Chicago
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Prebieha náborFáza 1/2
- Research Site, Chicago
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Prebieha náborFáza 2
- University of Chicago Comprehensive Cancer Center, Chicago
ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
Prebieha náborFáza 1
- University of Chicago Comprehensive Cancer Center, Chicago
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Prebieha náborFáza 1/2
- University of Chicago, Chicago
Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)
Prebieha nábor
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
Štúdie Burkitov lymfóm v iných mestách
- Houston, TX21 štúdií
- Milwaukee, WI16 štúdií
- Philadelphia, PA16 štúdií
- New York City, NY14 štúdií
- Cincinnati, OH12 štúdií
- Atlanta, GA12 štúdií
- Seattle, WA11 štúdií
- Durham, NC10 štúdií
- Boston, MA10 štúdií
- Los Angeles, CA10 štúdií
- Aurora, CO10 štúdií
- Kansas City, MO10 štúdií
Iné štúdie v Chicago
- Nemalobunkový karcinóm pľúc61 štúdií
- Rakovina prsníka58 štúdií
- Rakovina (všetky typy)51 štúdií
- Metastatická rakovina45 štúdií
- Rakovina prostaty45 štúdií
- Obézita41 štúdií
- Rakovina pľúc41 štúdií
- Rakovina vaječníkov36 štúdií
- Cievna mozgová príhoda34 štúdií
- Kolorektálny karcinóm33 štúdií
- Srdcové zlyhanie31 štúdií
- Nadváha28 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.